Chemogenomic screening identifies the Hsp70 co-chaperone DNAJA1 as a hub for anticancer drug resistance.

MLA

Nitika, et al. “Chemogenomic Screening Identifies the Hsp70 Co-Chaperone DNAJA1 as a Hub for Anticancer Drug Resistance.” Scientific Reports, vol. 10, no. 1, Aug. 2020, p. 13831. EBSCOhost, https://doi.org/10.1038/s41598-020-70764-x.

APA

Nitika, Blackman, J. S., Knighton, L. E., Takakuwa, J. E., Calderwood, S. K., & Truman, A. W. (2020). Chemogenomic screening identifies the Hsp70 co-chaperone DNAJA1 as a hub for anticancer drug resistance. Scientific Reports, 10(1), 13831. https://doi.org/10.1038/s41598-020-70764-x

Chicago

Nitika, Jacob S Blackman, Laura E Knighton, Jade E Takakuwa, Stuart K Calderwood, and Andrew W Truman. 2020. “Chemogenomic Screening Identifies the Hsp70 Co-Chaperone DNAJA1 as a Hub for Anticancer Drug Resistance.” Scientific Reports 10 (1): 13831. doi:10.1038/s41598-020-70764-x.